Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies

Wayne State University

Status: Completed

Conditions: Multiple Sclerosis

Study type: Observational

Funder types: Other

Identifiers

NCT01020370

CAMMS030081ST

Details and patient eligibility

About

The primary goal of this study will be to explore the reparative and regenerative potential of alemtuzumab in RRMS patients who are participating in the CARE MS I and CARE MS II studies using conventional and non-conventional MRI sequences.

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Participating in either the CARE MS I or CARE MS II studies

Exclusion criteria

• Not a participant in the CARE MS I or CARE MS II studies

Trial design

0 participants in 2 patient groups

Alemtuzumab Group

Interferon Beta-1a SC Group